메뉴 건너뛰기




Volumn 4, Issue 3, 2007, Pages 149-152

Effects of telmisartan on hypertensive patients with dyslipidemia and insulin resistance

Author keywords

Hypertension; Insulin resistance; Lipid metabolism; Telmisartan

Indexed keywords

ENALAPRIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TELMISARTAN; TRIACYLGLYCEROL;

EID: 35948937604     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (8)
  • 1
    • 17844397222 scopus 로고    scopus 로고
    • Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals
    • Ishizaka H, Ishizaka Y, Toda E, et al. Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res 2005;28:27-34.
    • (2005) Hypertens Res , vol.28 , pp. 27-34
    • Ishizaka, H.1    Ishizaka, Y.2    Toda, E.3
  • 2
    • 1542547460 scopus 로고    scopus 로고
    • Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gamma modulating activity
    • Benson SC, Pershadsingh HA, Ho CI, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gamma modulating activity. Hypertension 2004; 43: 993-1002.
    • (2004) Hypertension , vol.43 , pp. 993-1002
    • Benson, S.C.1    Pershadsingh, H.A.2    Ho, C.I.3
  • 3
    • 0041332950 scopus 로고    scopus 로고
    • The telmisartan program of research to show telmisartan end-organ protection program
    • Weber M. The telmisartan program of research to show telmisartan end-organ protection program. Hypertension 2003; 21(Suppl6): S37-S46.
    • (2003) Hypertension , vol.21 , Issue.SUPPL.6
    • Weber, M.1
  • 4
    • 0032788508 scopus 로고    scopus 로고
    • Angiotensin receptor antagonists: An emerging new class of cardiovascular therapeutics
    • Timmernans PB. Angiotensin receptor antagonists: an emerging new class of cardiovascular therapeutics. Hypertens Res 1999; 22: 147-53.
    • (1999) Hypertens Res , vol.22 , pp. 147-153
    • Timmernans, P.B.1
  • 5
    • 1942467808 scopus 로고    scopus 로고
    • Safety of telmisartan in patients with arterial hypertension: An open-label observational study
    • Michel MC, Bohner H, Koster J, et al. Safety of telmisartan in patients with arterial hypertension: an open-label observational study. Drug Saf 2004;27:335-44.
    • (2004) Drug Saf , vol.27 , pp. 335-344
    • Michel, M.C.1    Bohner, H.2    Koster, J.3
  • 6
    • 0346888591 scopus 로고    scopus 로고
    • Ingino C.Farsango C, Laucevicius A, et al. An open-label study investigating the efficacy and safety of 12-96 weeks of telmisartan treatment in patients with hypertension. Int Med Res 2003; 31: 561-74.
    • Ingino C.Farsango C, Laucevicius A, et al. An open-label study investigating the efficacy and safety of 12-96 weeks of telmisartan treatment in patients with hypertension. Int Med Res 2003; 31: 561-74.
  • 7
    • 25844490022 scopus 로고    scopus 로고
    • Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling
    • Takai S, Kirimura K, Denan JIN, et al. Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling. Hypertens Res 2005;28: 593-600.
    • (2005) Hypertens Res , vol.28 , pp. 593-600
    • Takai, S.1    Kirimura, K.2    Denan, J.I.N.3
  • 8
    • 4344569280 scopus 로고    scopus 로고
    • Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: A randomized, double-blind, placebo-controlled 12-month study
    • Derosa G, Ragonesi PD, Mugellini A, et al. Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study. Hypertens Res 2004;27: 457-64.
    • (2004) Hypertens Res , vol.27 , pp. 457-464
    • Derosa, G.1    Ragonesi, P.D.2    Mugellini, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.